LSGPA: The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) Invests in Two Central Pennsylvania Life Sciences Companies
The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) announced today that it has made follow-on investments in two of its portfolio companies – MacuLogix, Inc. and Micro Interventional Devices, Inc. Each company is receiving a $250,000 investment.
MacuLogix, Inc. of Hummelstown, Pennsylvania recently launched an FDA-approved device for early detection of age-related macular degeneration (AMD), a leading cause of blindness in adults. The device, called AdaptDx®, helps identify individuals at the earliest possible stage of AMD. LSGPA’s $250K investment was part of a $5 million round led by Fisk Ventures, LLC. MacuLogix plans to expand commercialization of their novel diagnostic tool.
Micro Interventional Devices, Inc. (MID) is an emerging cardiovascular medical device company based in Newtown, Pennsylvania. The company’s lead technology is Permaseal™, a device used to provide access and closure via the apex of the heart. Permaseal utilizes soft tissue PolyCorTM anchors to provide highly effective wound closure after structural heart repair procedures such as a Transcatheter Aortic Valve Replacement (TAVR). LSGPA’s $250K investment was part of a $1.5 million round, led by Originate Ventures. This investment will help Micro Interventional obtain needed regulatory approval and begin commercial sales.
Read more at LSGPA.com